Open Access Highly Accessed Research article

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Pablo Ureña-Torres*, Dominique Prié, Karim Keddad, Peter Preston, Paul Wilde, Hong Wan and J Brian Copley

BMC Nephrology 2014, 15:71  doi:10.1186/1471-2369-15-71

Article Metrics

1582
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 99 accesses
  • Last 365 days: 1582 accesses
  • All time: 1582 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information